Valuation: Karex

Market Cap 52Cr 13Cr 11Cr 10Cr 9.37Cr 18Cr 1.2TCr 18Cr 120.26Cr 47Cr 599.1Cr 47Cr 46Cr 1.99TCr P/E 2026 *
-163x
P/E 2027 * 23.3x
Enterprise Value 52Cr 13Cr 11Cr 10Cr 9.37Cr 18Cr 1.2TCr 18Cr 120.26Cr 47Cr 599.1Cr 47Cr 46Cr 1.99TCr EV / Sales 2026 *
1.07x
EV / Sales 2027 * 0.96x
Free-Float
39.15%
Yield 2026 *
2.11%
Yield 2027 * 1.77%
1 day+2.04%
1 week+1.01%
1 month+4.17%
3 months-1.96%
6 months-19.35%
Current year-29.08%
1 week 0.48
Extreme 0.475
0.5
1 month 0.43
Extreme 0.43
0.54
Current year 0.43
Extreme 0.43
0.73
1 year 0.43
Extreme 0.43
1.05
3 years 0.43
Extreme 0.43
1.09
5 years 0.32
Extreme 0.325
1.09
10 years 0.26
Extreme 0.26
2.64
Manager TitleAgeSince
Chief Executive Officer 48 29/07/2013
Director of Finance/CFO 49 30/06/2025
Chief Tech/Sci/R&D Officer 71 27/09/2012
Director TitleAgeSince
Director/Board Member 71 27/09/2012
Director/Board Member 83 30/11/2012
Director/Board Member 48 25/02/2020
Date Insider Type Main position Quantity % Market Cap.
16/07/26 Free

Director

80,000 0.0076%
16/07/26 Free

Chief Technology Officer

80,000 0.0076%
16/07/26 Free

Chief Executive Officer

80,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+1.01%-27.01%-3.85% 13Cr
+3.03%+2.67%+611.51%+8,396.97% 325.88Cr
-2.74%-8.45% - - 20Cr
-0.89%+0.91%-19.57%-36.21% 5.02Cr
Average +0.36%-0.75%+188.31%+2,785.64% 90.89Cr
Weighted average by Cap. +2.62%+3.51%+578.62%+7,962.40%

Financials

2026 *2027 *
Net sales 48Cr 12Cr 10Cr 9.54Cr 8.76Cr 17Cr 1.12TCr 17Cr 112.48Cr 44Cr 560.34Cr 44Cr 43Cr 1.86TCr 54Cr 13Cr 11Cr 11Cr 9.72Cr 18Cr 1.24TCr 19Cr 124.79Cr 49Cr 621.7Cr 49Cr 48Cr 2.06TCr
Net income -58.2L -14.21L -12.33L -11.5L -10.56L -19.98L -14Cr -20.2L -1.36Cr -53L -6.75Cr -53.35L -52.18L -22Cr 2.28Cr 55.77L 48.43L 45.15L 41.48L 78.45L 53Cr 79.31L 5.32Cr 2.08Cr 27Cr 2.09Cr 2.05Cr 88Cr
Net Debt - -
Logo Karex
Karex Berhad is a Malaysia-based investment holding company. The Company has three segments. Sexual Wellness segment is engaged in the sale of condoms, personal lubricants and sex toys. Medical segment is engaged in the sale of catheters, probe covers, human immunodeficiency virus (HIV) and pregnancy test kits, and other medical related products. Other segment is engaged in the sale of products not related to sexual wellness and medical. Its subsidiaries, including Hevea Medical Sdn. Bhd., Innolatex Sdn. Bhd., Innolatex (Thailand) Limited, Karex Industries Sdn. Bhd. and Medical-Latex (Dua) Sdn. Bhd. are engaged in the manufacturing and selling of condoms, rubber products, personal lubricants, and others. Its subsidiary, Karex Marketing Sdn. Bhd. engages in manufacturing and selling hand sanitizers, condoms, personal lubricants, and others. Its subsidiaries, Karex Global Limited, Karex Holdings Sdn. Bhd., Karex International Sdn. Bhd. are engaged in investment holding activity.
Employees
3,061
Date Price Change Volume
05/26/05 MYR 0.5000 +2.04% 11,000
04/26/04 MYR 0.4900 -1.01% 1,37,400
03/26/03 MYR 0.4950 -1.00% 1,25,100
31/26/31 MYR 0.5000 +5.26% 1,16,600
30/26/30 MYR 0.4750 -4.04% 6,44,800
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4900MYR
Average target price
0.5633MYR
Spread / Average Target
+14.97%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 5247 Stock